Skip to main content
. 2021 Jun 8;7:GO.21.00051. doi: 10.1200/GO.21.00051

FIG 1.

FIG 1

(A) Distribution of pathogenic or likely pathogenic and VUS BRCA1/2 mutations per mutation type (n = 61). (B) BRCA1 (n = 41). (C) BRCA2 (n = 20). VUS, variant of uncertain significance.